Pharmacological inhibition in the ataxia telangiectasia and Rad3-connected protein serine/threonine kinase (ATR; also referred to as FRAP-related protein (FRP1)) has emerged as a promising strategy for most cancers treatment method that exploits synthetic lethal interactions with proteins linked to DNA damage fix, overcomes resistance to other therapies and enhances antitumour https://samuelv000ite2.laowaiblog.com/profile